Journal Home
Search for

Volume 32, Issue 6, Pages 918-922 (June 2006)


View previous. 19 of 47 View next.

Rescue of failed filtering blebs with ab interno trephination

Wisam A. Shihadeh, MD, Robert Ritch, MDCorresponding Author Informationemail address, Jeffrey M. Liebmann, MD

Accepted 8 November 2005.

We evaluated the effectiveness of ab interno automated trephination as a technique for rescuing failed mature filtering blebs. A retrospective chart review of 40 failed blebs of 38 patients who had a posttrephination follow-up period of at least 3 months was done. With success defined as intraocular pressure (IOP) <21 mm Hg and at least a 20% reduction from baseline on the same or fewer number of pretrephination medications, 30/40 eyes (75%) fit these criteria over the entire course of follow-up. Among all 40 eyes, there was a significant reduction of IOP from pretrephination to 3 months (P<.001). The percentage of patients requiring 2 or more medications declined from 90% pretrephination to 21% at 3 months (P<.0001), and was stable thereafter. Some patients were able to eliminate all medications. Patients who did not meet the criteria of success regained successful IOP control with other modalities of management. Complications were few. We believe that ab interno trephination is an excellent option for rescuing selected failed filtering blebs.

From the Department of Ophthalmology (Shihadeh, Ritch), The New York Eye and Ear Infirmary, New York, the Department of Ophthalmology (Ritch), New York Medical College, Valhalla, the Department of Ophthalmology (Liebmann), Manhattan Eye, Ear & Throat Hospital, New York, and the Department of Ophthalmology (Liebmann), New York University Medical Center, New York, New York, USA

Corresponding Author InformationReprint requests to Robert Ritch, MD, Professor and Chief, Glaucoma Service, Department of Ophthalmology, The New York Eye and Ear Infirmary, 310 East 14th Street, New York, New York 10003, USA.

 Supported in part by the Joseph and Geraldine LaMotta Research Fund of the New York Glaucoma Research Institute, New York, New York, USA.

Presented in part at the annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, USA, April 2004.

No author has a financial or proprietary interest in any material or method mentioned.

PII: S0886-3350(06)00235-5

doi:10.1016/j.jcrs.2006.02.045


View previous. 19 of 47 View next.